Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Holdings Decreased by Pinnacle Wealth Planning Services Inc.

Pinnacle Wealth Planning Services Inc. lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 18.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,101 shares of the medical equipment provider’s stock after selling 462 shares during the quarter. Pinnacle Wealth Planning Services Inc.’s holdings in Intuitive Surgical were worth $1,097,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Atala Financial Inc acquired a new stake in Intuitive Surgical during the 4th quarter valued at $25,000. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical during the fourth quarter valued at $28,000. Hurley Capital LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth about $28,000. Finally, Summit Securities Group LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth about $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $539.54 on Monday. Intuitive Surgical, Inc. has a one year low of $396.15 and a one year high of $616.00. The company’s fifty day moving average price is $511.55 and its two-hundred day moving average price is $538.09. The company has a market capitalization of $193.38 billion, a price-to-earnings ratio of 84.17, a PEG ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the prior year, the company posted $1.50 EPS. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ISRG. Barclays lowered their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the stock a “buy” rating in a report on Monday, April 14th. Evercore ISI lowered their price objective on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a research report on Wednesday, April 23rd. Bernstein Bank upped their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Finally, Leerink Partners lifted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $596.05.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 2,401 shares of the business’s stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at $205,093. The trade was a 87.18% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now owns 6,371 shares of the company’s stock, valued at $3,312,920. This trade represents a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 32,700 shares of company stock valued at $16,865,621 over the last 90 days. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.